TTM
$5.88B
YoY change
-12.2%
5Y CAGR
-5.2%
Peak year (FY2011)
$11.6B
Cumulative EBITDA
$159B
EBITDA history chart for MetLife (MET) from 2016 to 2025
Latest: $6.48B
EBITDA growth chart for MetLife (MET) from 2016 to 2025
Latest: -12.2%
EBITDA history table for MetLife (MET) from 1995 to 2025
| FY2025 | $6.48B | -12.2% | -$898M | ||
| FY2024 | $7.37B | +87.8% | +$3.45B | ||
| FY2023 | $3.93B | -50.8% | -$4.05B | ||
| FY2022 | $7.98B | -21.3% | -$2.16B | ||
| FY2021 | $10.1B | +19.8% | +$1.67B | ||
| FY2020 | $8.46B | +0.9% | +$79M | ||
| FY2019 | $8.38B | +4.0% | +$323M | ||
| FY2018 | $8.06B | +47.6% | +$2.6B | ||
| FY2017 | $5.46B | -10.3% | -$630M | ||
| FY2016 | $6.09B | -18.9% | -$1.42B | ||
| FY2015 | $7.51B | -30.0% | -$3.22B | ||
| FY2014 | $10.7B | +77.5% | +$4.69B | ||
| FY2013 | $6.05B | +78.2% | +$2.65B | ||
| FY2012 | $3.39B | -70.7% | -$8.19B | ||
| FY2011 | $11.6B | +93.1% | +$5.59B | ||
| FY2010 | $6B | -304.3% | +$8.94B | ||
| FY2009 | -$2.94B | -147.7% | -$9.09B | ||
| FY2008 | $6.16B | -9.7% | -$663M | ||
| FY2007 | $6.82B | +33.2% | +$1.7B | ||
| FY2006 | $5.12B | -3.5% | -$183M | ||
| FY2005 | $5.3B | +23.2% | +$999M | ||
| FY2004 | $4.31B | +30.4% | +$1B | ||
| FY2003 | $3.3B | +43.1% | +$995M | ||
| FY2002 | $2.31B | +79.3% | +$1.02B | ||
| FY2001 | $1.29B | +16.1% | +$178M | ||
| FY2000 | $1.11B | -9.1% | -$111M | ||
| FY1999 | $1.22B | -39.9% | -$811M | ||
| FY1998 | $2.03B | +71.8% | +$849M | ||
| FY1997 | $1.18B | -11.5% | -$153M | ||
| FY1996 | $1.34B | +20.7% | +$229M | ||
| FY1995 | $1.11B | — | — |
- FY2025$6.48B-12.2%
- FY2024$7.37B+87.8%
- FY2023$3.93B-50.8%
- FY2022$7.98B-21.3%
- FY2021$10.1B+19.8%
- FY2020$8.46B+0.9%
- FY2019$8.38B+4.0%
- FY2018$8.06B+47.6%
- FY2017$5.46B-10.3%
- FY2016$6.09B-18.9%
- FY2015$7.51B-30.0%
- FY2014$10.7B+77.5%
- FY2013$6.05B+78.2%
- FY2012$3.39B-70.7%
- FY2011$11.6B+93.1%
- FY2010$6B-304.3%
- FY2009-$2.94B-147.7%
- FY2008$6.16B-9.7%
- FY2007$6.82B+33.2%
- FY2006$5.12B-3.5%
- FY2005$5.3B+23.2%
- FY2004$4.31B+30.4%
- FY2003$3.3B+43.1%
- FY2002$2.31B+79.3%
- FY2001$1.29B+16.1%
- FY2000$1.11B-9.1%
- FY1999$1.22B-39.9%
- FY1998$2.03B+71.8%
- FY1997$1.18B-11.5%
- FY1996$1.34B+20.7%
- FY1995$1.11B—
EBITDA values are taken from MetLife's reported income statements (quarterly 10-Q and annual 10-K filings with the U.S. Securities and Exchange Commission). Each row shows the period end date and the filing date. YoY compares each figure to the same period one year earlier. Amounts are in USD as filed.
About EBITDA at MetLife (MET)
According to MetLife's latest reported financial statements, the company's current EBITDA (TTM) is $5.88B. EBITDA stands for earnings before interest, taxes, depreciation, and amortization. It is a common proxy for operating cash generation that strips out non-cash charges (depreciation and amortization) and capital structure effects (interest, taxes). Useful for comparing companies with different leverage and asset bases — see operating income and net income for fully GAAP figures.
Headline TTM above sums the four reported quarters through (reported ). Chart and table below cover the full reported history back to .
MetLife (MET) most recent annual EBITDA stands at $6.48B (2025) – declined 12.2% year-over-year.
MetLife EBITDA compound annual growth for the 2020–2025 (5 years) window is -5.2%, with a net decline across the window.
MetLife EBITDA peaked at $11.6B in 2011; the latest annual figure is $6.48B in 2025 (44.1% below peak).
$11.6B stands as the all-time-high annual EBITDA, posted in 2011, against a low of -$2.94B during 2009.
MetLife EBITDA by Year
MetLife EBITDA 2025: $6.48B
MetLife posted EBITDA of $6.48B in 2025, declined 12.2% below 2024.
MetLife EBITDA 2024: $7.37B
In 2024, MetLife reported EBITDA of $7.37B, surged 87.8% from 2023.
MetLife EBITDA 2023: $3.93B
MetLife EBITDA in 2023 was $3.93B, plunged 50.8% below 2022.
MetLife EBITDA 2022: $7.98B
2022's EBITDA for MetLife came in at $7.98B, declined 21.3% below 2021.
MetLife EBITDA 2021: $10.1B
MetLife EBITDA in 2021 was $10.1B.
See more financial history for MetLife (MET).
Sector peers by EBITDA
Financial Services peers of MetLife (MET), ranked by their latest EBITDA
| $81.4B | |
| $72.4B | |
| $40B | |
| $29.3B | |
| $26.6B | |
| $26B | |
| $24B | |
| $20.2B |
- $81.4B
- $29.3B
- $26.6B
- $26B
- $20.2B
Frequently asked questions
MetLife (MET) Key Financials
Charts, filings, and peer comparison for every metric
Explore more
Deep-dives across the income statement, cash flow, capital return, and valuation
- Buybacks4.83% TTM
- Dividend Profile2.37% yield
- Dividend Calculator
- Dividend Forecast
- Dividend Capture
- Stock Split History1 split
How this company returns cash to shareholders — buybacks, dividends, and stock splits.